Note: Certain medical conditions or medications may mean GLP-1 therapy is not right for you
GLP-1 medications are also known as GLP-1 agonists
If approved, CagriSema would become the first GLP-1 and amylin combination product to reach the market for obesity, a genuinely novel mechanism designation that Novo Nordisk regards as a meaningful point of differentiation regardless of the tirzepatide comparison
"Weight-loss supplements, along with those for bodybuilding and sexual enhancement, are commonly found to contain pharmaceutical drugs or illegal chemicals," says Pieter Cohen, M.D., an assistant professor of medicine at Harvard Medical School and an expert on adulterated dietary supplements
This may result from improved metabolic regulation due to DPP-4 inhibition, reduced glucagon levels, and enhanced insulin activity